Less than a week after Teva Pharmaceutical Industries sued the FDA to block competitors from marketing generic versions of its blockbuster multiple sclerosis drug Copaxone, the company's lawyers are back where they started.
May 15, 2014 at 04:03 PM
1 minute read
Well, that was fast.
Less than a week after Teva Pharmaceutical Industries Ltd. sued the U.S. Food and Drug Administration to block competitors from marketing generic versions of its blockbuster multiple sclerosis drug Copaxone, the company’s lawyers at Kirkland & Ellis are back where they started.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
U.S. District Court for the Northern District of CaliforniaThe current term of office for United States Magistrate Judge Susan van Keulen in...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
